iNOS-selective inhibitors for cancer prevention: promise and progress

NB Janakiram, CV Rao - Future medicinal chemistry, 2012 - Taylor & Francis
Nitric oxide (NO) is involved in various physiological functions and its role in tumorigenesis
has been well studied. A large majority of human and experimental tumors appear to …

Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological …

R Moradi‐Marjaneh, SM Hassanian… - Journal of cellular …, 2019 - Wiley Online Library
Reactive oxygen species (ROS) are produced by mitochondria during metabolism. In
physiological states, the production of ROS and their elimination by antioxidants are kept in …

Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer

Y Shen, M Sun, J Zhu, M Wei, H Li, P Zhao, J Wang… - Molecular omics, 2021 - pubs.rsc.org
Metabolic reprogramming is a hallmark of cancer, which is still far from being fully
understood in colorectal cancer. In order to characterize the metabolic changes in colorectal …

Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis

M Takahashi, M Mutoh, Y Shoji, H Sato, Y Kamanaka… - Nitric Oxide, 2006 - Elsevier
The expression of inducible nitric oxide synthase (iNOS) is markedly elevated in rat colon
cancers induced by azoxymethane (AOM). In addition, iNOS can be detected in most …

Reactive oxygen species and colorectal cancer

S Lin, Y Li, AA Zamyatnin Jr, J Werner… - Journal of cellular …, 2018 - Wiley Online Library
Colorectal cancer (CRC) has become the fourth leading cause of cancer‐related death in
the worldwide. It is urgent to find more effective therapeutic strategies for it. Reactive oxygen …

Arginine and the metabolic regulation of nitric oxide synthesis in cancer

R Keshet, A Erez - Disease models & mechanisms, 2018 - journals.biologists.com
Nitric oxide (NO) is a signaling molecule that plays important roles in diverse biological
processes and thus its dysregulation is involved in the pathogenesis of various disorders. In …

Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal cancers

GA de Oliveira, RYS Cheng, LA Ridnour… - Antioxidants & redox …, 2017 - liebertpub.com
Significance: Gastrointestinal (GI) cancer taken together constitutes one of the most common
cancers worldwide with a broad range of etiological mechanisms. In this review, we have …

[HTML][HTML] Transcriptional and metabolomic analysis of L-arginine/nitric oxide pathway in inflammatory bowel disease and its association with local inflammatory and …

M Krzystek-Korpacka, M G. Fleszar… - International Journal of …, 2020 - mdpi.com
L-arginine/nitric oxide pathway in Crohn's disease (CD) and ulcerative colitis (UC) is poorly
investigated. The aim of current study is to quantify pathway serum metabolites in 52 CD (40 …

Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K …

S Demirkol Canlı, EG Seza, I Sheraj, I Gömçeli… - …, 2020 - academic.oup.com
Abstract AKR1B1 and AKR1B10, members of the aldo-keto reductase family of enzymes that
participate in the polyol pathway of aldehyde metabolism, are aberrantly expressed in colon …

Analysis of metabonomic profiling alterations in a mouse model of colitis-associated cancer and 2-deoxy-d-glucose treatment

P Yang, Z Li, L Zhang, H Li, Z Li - RSC advances, 2016 - pubs.rsc.org
Inflammation is well recognized to be associated with tumorigenesis, cancer progression
and tumor metabolism of colorectal cancer (CRC). 2-Deoxy-D-glucose (2-DG), a glycolytic …